Cyclosporin	O
A-resistant	O
transactivation	O
of	O
the	O
IL-2	B-DNA
promoter	I-DNA
requires	O
activity	O
of	O
okadaic	B-protein
acid-sensitive	I-protein
serine/threonine	I-protein
phosphatases	I-protein
.	O

Expression	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
requires	O
activation	O
of	O
T	B-cell_type
cells	I-cell_type
through	O
stimulation	O
of	O
the	O
TCR	B-protein
and	O
costimulation	O
through	O
accessory	B-protein
receptors	I-protein
.	O

We	O
have	O
found	O
recently	O
that	O
okadaic	B-protein
acid-sensitive	I-protein
Ser/Thr	I-protein
phosphatases	I-protein
are	O
involved	O
in	O
a	O
cyclosporin	O
A-insensitive	O
pathway	O
that	O
selectively	O
transmits	O
costimulatory	O
signals	O
.	O

In	O
this	O
study	O
,	O
we	O
analyzed	O
whether	O
activities	O
of	O
these	O
phosphatases	O
are	O
necessary	O
for	O
the	O
expression	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
.	O

In	O
both	O
activated	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
and	O
activated	B-cell_line
tumorigenic	I-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
IL-2	B-protein
gene	O
expression	O
was	O
blocked	O
at	O
the	O
transcriptional	O
level	O
by	O
okadaic	O
acid	O
.	O

The	O
transcription	B-protein
factors	I-protein
active	O
at	O
the	O
IL-2	B-DNA
promoter	I-DNA
were	O
differentially	O
influenced	O
:	O
upon	O
down-modulation	O
of	O
okadaic	B-protein
acid-sensitive	I-protein
phosphatases	I-protein
,	O
transactivation	O
by	O
octamer	O
,	O
NF-kappa	B-protein
B	I-protein
,	O
and	O
NF	B-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
proteins	I-protein
was	O
abrogated	O
,	O
while	O
transactivation	O
by	O
AP-1	B-protein
proteins	I-protein
was	I-protein
even	I-protein
enhanced	I-protein
.	I-protein

iin	NULL
33	NULL
W	NULL
Te	NULL
a	NULL
3	NULL
g	NULL
_-_	NULL
The	NULL
Attune	NULL
``	NULL
NXT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
_-	NULL
-	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
f	NULL
+	NULL
invitrogen	NULL
Cyclosporin	NULL
A-Resistant	NULL
Transactivation	NULL
of	NULL
f	NULL
~	NULL
*A	NULL
The	NULL
10	NULL
ﬁxlﬁiﬁlgﬁillélo	NULL
gy	NULL
the	NULL
IL-2	NULL
Promoter	NULL
Requires	NULL
Activity	NULL
of	NULL
Okadaic	NULL
Acid-Sensitive	NULL
Serine/Threonine	NULL
Phosphatases	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Gabriele	NULL
Nebl	NULL
,	NULL
Stefan	NULL
C.	NULL
Meuer	NULL
and	NULL
Yvonne	NULL
Samstag	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:1803-1810	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/4/1803	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
53	NULL
articles	NULL
,	NULL
19	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/4/1803	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Cyclosporin	NULL
A-Resistant	NULL
Transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
Promoter	NULL
Requires	NULL
Activity	NULL
of	NULL
Okadaic	NULL
Acid-Sensitive	NULL
Serine/Threonine	NULL
Phosphatases	NULL
'	NULL
Gabriele	NULL
Nebl	NULL
,	NULL
``	NULL
Stefan	NULL
C.	NULL
Meuer	NULL
,	NULL
and	NULL
Yvonne	NULL
Samstag	NULL
Expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
requires	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
through	NULL
stimulation	NULL
of	NULL
the	NULL
TCR	NULL
and	NULL
costimulation	NULL
through	NULL
accessory	NULL
receptors	NULL
.	NULL

We	NULL
have	NULL
found	NULL
recently	NULL
that	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
are	NULL
involved	NULL
in	NULL
a	NULL
cyclosporin	NULL
A-insensitive	NULL
pathway	NULL
that	NULL
selectively	NULL
transmits	NULL
costimulatory	NULL
signals	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
activities	NULL
of	NULL
these	NULL
phosphatases	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

In	NULL
both	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
activated	NULL
tumorigenic	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
blocked	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
active	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
were	NULL
differentially	NULL
influenced	NULL
:	NULL
upon	NULL
down-modulation	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
,	NULL
transactivation	NULL
by	NULL
oc-tamer	NULL
,	NULL
NF-B	NULL
,	NULL
and	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
proteins	NULL
was	NULL
abrogated	NULL
,	NULL
while	NULL
transactivation	NULL
by	NULL
AP-1	NULL
proteins	NULL
was	NULL
even	NULL
enhanced	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
1803-1810.	NULL
ull	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
requires	NULL
two	NULL
types	NULL
of	NULL
sig-nals	NULL
:	NULL
those	NULL
provided	NULL
through	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
,	NULL
and	NULL
in	NULL
addition	NULL
,	NULL
those	NULL
induced	NULL
by	NULL
stimulation	NULL
of	NULL
coreceptors	NULL
such	NULL
as	NULL
CD2	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
or	NULL
CD28	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
costimulation	NULL
leads	NULL
to	NULL
anergy	NULL
or	NULL
apoptosis	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Signaling	NULL
events	NULL
induced	NULL
by	NULL
coreceptors	NULL
overlap	NULL
in	NULL
part	NULL
with	NULL
the	NULL
TCR	NULL
signaling	NULL
pathway	NULL
.	NULL

Recently	NULL
,	NULL
intracellular	NULL
reactions	NULL
clearly	NULL
independent	NULL
of	NULL
the	NULL
TCR	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
depends	NULL
on	NULL
an	NULL
activation	NULL
of	NULL
both	NULL
coreceptor-	NULL
and	NULL
TCR-triggered	NULL
signal-transduction	NULL
pathways	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

These	NULL
influence	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
mediate	NULL
IL-2	NULL
transcription	NULL
,	NULL
namely	NULL
Oct	NULL
,	NULL
``	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
NF-AT	NULL
proteins	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
proteins	NULL
,	NULL
which	NULL
requires	NULL
their	NULL
release	NULL
from	NULL
inactive	NULL
cyto-plasmic	NULL
complexes	NULL
(	NULL
10-13	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
regulate	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
AP-1	NULL
proteins	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

The	NULL
Ca/calmodulin-regulated	NULL
Ser/Thr	NULL
phosphatase	NULL
2B	NULL
(	NULL
PP2B	NULL
)	NULL
/calcineurin	NULL
regulates	NULL
the	NULL
nuclear	NULL
entry	NULL
of	NULL
the	NULL
cytoplas-mic	NULL
components	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-AT	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

Additional	NULL
phosphatases	NULL
,	NULL
namely	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
,	NULL
were	NULL
recently	NULL
identified	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
a	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
-insensitive	NULL
pathway	NULL
,	NULL
which	NULL
is	NULL
induced	NULL
through	NULL
the	NULL
CD2	NULL
and	NULL
CD28	NULL
coreceptors	NULL
(	NULL
6	NULL
,	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Ser/Thr	NULL
phosphatases	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
gene	NULL
families	NULL
PPM	NULL
and	NULL
PPP	NULL
.	NULL

The	NULL
PPP	NULL
family	NULL
comprises	NULL
the	NULL
subfamilies	NULL
1	NULL
,	NULL
2A	NULL
,	NULL
2B	NULL
,	NULL
and	NULL
5	NULL
.	NULL

The	NULL
phosphatases	NULL
of	NULL
sub	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Ruprecht-Karls-University	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
19	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
(	NULL
Grants	NULL
DFG-§a393/2-1	NULL
(	NULL
to	NULL
Y.S	NULL
.	NULL
)	NULL

and	NULL
SFB405/A4	NULL
)	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprints	NULL
to	NULL
Dr.	NULL
Gabriele	NULL
Nebl	NULL
,	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Ruprecht-Karls-University	NULL
,	NULL
Im	NULL
Neuenheimer	NULL
Feld	NULL
305	NULL
,	NULL
69120	NULL
Heidelberg	NULL
,	NULL
Ger-many	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
066	NULL
@	NULL
ix.urz.uni-heidelberg.de	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
Oct	NULL
,	NULL
octamer	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NF-KB	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
;	NULL
OAP	NULL
,	NULL
octamer-l-associated	NULL
protein	NULL
;	NULL
PBL-T	NULL
,	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
families	NULL
1	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
5	NULL
are	NULL
sensitive	NULL
to	NULL
okadaic	NULL
acid	NULL
(	NULL
22	NULL
)	NULL
,	NULL
while	NULL
PP2B	NULL
is	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

During	NULL
the	NULL
CD2/CD28-induced	NULL
signaling	NULL
pathway	NULL
,	NULL
dephosphor-ylation	NULL
of	NULL
the	NULL
essential	NULL
phosphoprotein	NULL
pp19/cofilin	NULL
is	NULL
catalyzed	NULL
by	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
.	NULL

Since	NULL
dephosphory-lation	NULL
of	NULL
ppl9/cofilin	NULL
correlates	NULL
with	NULL
IL-2	NULL
production	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
influence	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
indeed	NULL
activities	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
are	NULL
necessary	NULL
to	NULL
achieve	NULL
transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
the	NULL
NF-AT	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
Oct	NULL
transcription	NULL
factor	NULL
proteins	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
,	NULL
tissue	NULL
culture	NULL
,	NULL
and	NULL
transfection	NULL
procedure	NULL
Human	NULL
primary	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

EL4	NULL
cells	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
(	NULL
ELA	NULL
)	NULL
or	NULL
10	NULL
%	NULL
(	NULL
Jurkat	NULL
)	NULL
FCS	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
1	NULL
%	NULL
penicillin/streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
cell	NULL
clone	NULL
IL-2-luc	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
pIL-ZlucZkb	NULL
(	NULL
23	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
B.	NULL
Schraven	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
transfected	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
,	NULL
using	NULL
1	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
per	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
.	NULL

The	NULL
constructs	NULL
used	NULL
were	NULL
pmoIL2-2k-luc	NULL
,	NULL
pmoIL2-321-luc	NULL
,	NULL
and	NULL
the	NULL
control	NULL
vector	NULL
pUCOOluc	NULL
;	NULL
octp-luc	NULL
,	NULL
NFxB-luc	NULL
,	NULL
NFAT-luc	NULL
,	NULL
and	NULL
the	NULL
control	NULL
vector	NULL
pGL2	NULL
(	NULL
25	NULL
)	NULL
;	NULL
5X	NULL
TRE-TATA	NULL
CAT	NULL
and	NULL
the	NULL
control	NULL
vector	NULL
TATA	NULL
CAT	NULL
(	NULL
26	NULL
)	NULL
;	NULL
and	NULL
4	NULL
%	NULL
oct-luc	NULL
and	NULL
the	NULL
control	NULL
vector	NULL
4X	NULL
oct	NULL
mut-lue	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Sixteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
split	NULL
in	NULL
aliquots	NULL
and	NULL
treated	NULL
with	NULL
various	NULL
stimulating	NULL
agents	NULL
.	NULL

The	NULL
concentrations	NULL
used	NULL
were	NULL
0.5	NULL
uM	NULL
okadaic	NULL
acid	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
;	NULL
0.1	NULL
pg/ml	NULL
CsA	NULL
(	NULL
Sandoz	NULL
,	NULL
Basel	NULL
,	NULL
Swit-zerland	NULL
)	NULL
;	NULL
10	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
;	NULL
180	NULL
nM	NULL
A23187	NULL
(	NULL
Sigma	NULL
)	NULL
;	NULL
10	NULL
pg/ml	NULL
CD2	NULL
Abs	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
3PT	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
;	NULL
and	NULL
1	NULL
pg/ml	NULL
CD28	NULL
Ab	NULL
9.3	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Luciferase	NULL
assay	NULL
and	NULL
CAT	NULL
assay	NULL
Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Pro-mega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
conducted	NULL
using	NULL
CAT	NULL
ELISA	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
RNA	NULL
and	NULL
Northern	NULL
analysis	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cells	NULL
by	NULL
a	NULL
guanidinium	NULL
isothiocyanate	NULL
method	NULL
.	NULL

Before	NULL
loading	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
(	NULL
1	NULL
%	NULL
in	NULL
1X	NULL
MOPS	NULL
;	NULL
1X	NULL
MOPS	NULL
equals	NULL
20	NULL
mM	NULL
MOPS	NULL
(	NULL
3-	NULL
[	NULL
N-morpholinopropanesulfonic	NULL
acid	NULL
,	NULL
5	NULL
mM	NULL
sodium	NULL
ac-etate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
)	NULL
,	NULL
RNA	NULL
samples	NULL
were	NULL
adjusted	NULL
to	NULL
25	NULL
%	NULL
formamide	NULL
,	NULL
1.1	NULL
M	NULL
formaldehyde	NULL
,	NULL
0.5X	NULL
MOPS	NULL
,	NULL
0.5	NULL
%	NULL
Ficoll	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
bromphenol	NULL
blue	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1804	NULL
After	NULL
electrophoresis	NULL
,	NULL
gels	NULL
were	NULL
blotted	NULL
onto	NULL
Hybond	NULL
N*	NULL
filters	NULL
(	NULL
Amer-sham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Prehybridization	NULL
and	NULL
hybridization	NULL
were	NULL
conducted	NULL
at	NULL
65°C	NULL
in	NULL
solution	NULL
HS	NULL
(	NULL
7	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
phosphate	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
phosphate	NULL
buffer	NULL
equals	NULL
2	NULL
M	NULL
Na	NULL
,	NULL
HPO,2H,0	NULL
,	NULL
0.34	NULL
%	NULL
phosphoric	NULL
acid	NULL
)	NULL
)	NULL
.	NULL

For	NULL
hybridization	NULL
,	NULL
cDNA	NULL
probes	NULL
(	NULL
G-actin	NULL
,	NULL
human	NULL
IL-2	NULL
,	NULL
murine	NULL
IL-2	NULL
(	NULL
30-32	NULL
)	NULL
)	NULL
were	NULL
labeled	NULL
radioactively	NULL
using	NULL
a	NULL
random	NULL
hexanucleotide	NULL
priming	NULL
procedure	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Blot	NULL
washes	NULL
(	NULL
at	NULL
65°C	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
0.04X	NULL
phosphate	NULL
buffer	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
0.04	NULL
%	NULL
phosphate	NULL
buffer	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
autoradiography	NULL
.	NULL

Nuclear	NULL
run-on	NULL
analysis	NULL
Nuclear	NULL
run-on	NULL
analysis	NULL
was	NULL
performed	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
,	NULL
using	NULL
cDNA	NULL
probes	NULL
for	NULL
the	NULL
B-actin	NULL
gene	NULL
,	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
the	NULL
c-jun	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
respective	NULL
transcripts	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
In	NULL
vivo	NULL
footprinting	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
oli-gonucleotide	NULL
primers	NULL
used	NULL
to	NULL
visualize	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
were	NULL
synthesized	NULL
according	NULL
to	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
band	NULL
intensities	NULL
was	NULL
performed	NULL
through	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograms	NULL
using	NULL
a	NULL
Saphir	NULL
Ultra	NULL
laser	NULL
densitometer	NULL
.	NULL

From	NULL
top	NULL
to	NULL
bottom	NULL
of	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
autoradiogram	NULL
,	NULL
an	NULL
intensity	NULL
profile	NULL
was	NULL
produced	NULL
using	NULL
the	NULL
Image	NULL
Quant	NULL
3.0	NULL
software	NULL
(	NULL
Fuji	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
intensity	NULL
values	NULL
of	NULL
individual	NULL
profile	NULL
peaks	NULL
were	NULL
determined	NULL
.	NULL

Intensity	NULL
values	NULL
of	NULL
affected	NULL
bands	NULL
were	NULL
related	NULL
to	NULL
the	NULL
intensity	NULL
value	NULL
of	NULL
a	NULL
nonaffected	NULL
band	NULL
in	NULL
the	NULL
same	NULL
area	NULL
of	NULL
the	NULL
gel	NULL
to	NULL
compensate	NULL
for	NULL
loading	NULL
differences	NULL
(	NULL
relative	NULL
intensity	NULL
values	NULL
)	NULL
.	NULL

For	NULL
graph	NULL
representation	NULL
,	NULL
relative	NULL
intensity	NULL
values	NULL
obtained	NULL
from	NULL
an	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
band	NULL
were	NULL
set	NULL
1	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
intensity	NULL
values	NULL
of	NULL
corresponding	NULL
bands	NULL
in	NULL
the	NULL
four	NULL
in	NULL
vivo	NULL
DNA	NULL
preparations	NULL
were	NULL
related	NULL
to	NULL
it	NULL
.	NULL

G	NULL
~*	NULL
``	NULL
of	NULL
the	NULL
Oct	NULL
site	NULL
,	NULL
G	NULL
**	NULL
of	NULL
the	NULL
OAP	NULL
site	NULL
,	NULL
G	NULL
'®	NULL
and	NULL
G*	NULL
of	NULL
the	NULL
NF-AT	NULL
site	NULL
,	NULL
and	NULL
G	NULL
'	NULL
and	NULL
G*	NULL
``	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
were	NULL
analyzed	NULL
as	NULL
individual	NULL
bands	NULL
,	NULL
while	NULL
G	NULL
'	NULL
and	NULL
G	NULL
'	NULL
of	NULL
the	NULL
ATGG	NULL
site	NULL
,	NULL
G	NULL
**	NULL
,	NULL
G	NULL
**	NULL
,	NULL
and	NULL
G	NULL
**	NULL
``	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
,	NULL
and	NULL
G*	NULL
and	NULL
G*	NULL
``	NULL
of	NULL
the	NULL
TGGGC	NULL
site	NULL
were	NULL
pooled	NULL
with	NULL
neighboring	NULL
bands	NULL
.	NULL

At	NULL
the	NULL
ATGG	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
TGGGC	NULL
sites	NULL
,	NULL
in	NULL
vivo	NULL
methylated	NULL
DNAs	NULL
are	NULL
hyperreactive	NULL
when	NULL
compared	NULL
with	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
situation	NULL
occurring	NULL
at	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
described	NULL
earlier	NULL
.	NULL

Its	NULL
significance	NULL
remains	NULL
unknown	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Results	NULL
Okadaic	NULL
acid	NULL
prevents	NULL
IL-2	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
Activation	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
(	NULL
PBL-T	NULL
)	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
mitogenic	NULL
Abs	NULL
directed	NULL
at	NULL
the	NULL
CD2	NULL
coreceptor	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
by	NULL
phorbolester	NULL
and	NULL
Ca	NULL
ionophore	NULL
(	NULL
PMA	NULL
+	NULL
A23187	NULL
)	NULL
.	NULL

CD2	NULL
triggering	NULL
provides	NULL
an	NULL
activation	NULL
signal	NULL
to	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Phorbolesters	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
whereas	NULL
Ca	NULL
ionophores	NULL
lead	NULL
to	NULL
an	NULL
elevation	NULL
of	NULL
intracellular	NULL
calcium	NULL
.	NULL

This	NULL
treatment	NULL
mimics	NULL
intracellular	NULL
signals	NULL
induced	NULL
by	NULL
antigenic	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
TCR/CD3	NULL
and	NULL
coreceptors	NULL
(	NULL
39	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
both	NULL
stimulation	NULL
protocols	NULL
induced	NULL
the	NULL
accumulation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
,	NULL
which	NULL
was	NULL
prevented	NULL
completely	NULL
when	NULL
okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
at	NULL
concentrations	NULL
known	NULL
to	NULL
inhibit	NULL
the	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
of	NULL
subfamilies	NULL
1	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
5	NULL
(	NULL
22	NULL
,	NULL
27	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
treatment	NULL
did	NULL
not	NULL
generally	NULL
affect	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
since	NULL
a	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
(	NULL
see	NULL
below	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
revealed	NULL
that	NULL
other	NULL
transcriptional	NULL
processes	NULL
were	NULL
ongoing	NULL
throughout	NULL
cell	NULL
treatment	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
inhibition	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
abrogates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
activated	NULL
PBL-T	NULL
cells	NULL
.	NULL

Okadaic	NULL
acid	NULL
blocks	NULL
IL-2	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
We	NULL
then	NULL
analyzed	NULL
the	NULL
mechanisms	NULL
underlying	NULL
the	NULL
inhibition	NULL
of	NULL
IL-2	NULL
expression	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
okadaic	NULL
acid	NULL
treatment	NULL
results	NULL
in	NULL
mRNA	NULL
destabilization	NULL
and/or	NULL
reduced	NULL
mRNA	NULL
synthesis	NULL
.	NULL

To	NULL
discriminate	NULL
OKADAIC	NULL
ACID-SENSITIVE	NULL
PHOSPHATASES	NULL
REGULATE	NULL
IL-2	NULL
EXPRESSION	NULL
<	NULL
9	NULL
6	NULL
a	NULL
&	NULL
_	NULL
,	NULL
+	NULL
$	NULL
a	NULL
n	NULL
3	NULL
2	NULL
.	NULL

0	NULL
V	NULL
VQ	NULL
A	NULL
&	NULL
m	NULL
IL-2	NULL
l	NULL
B-aclin	NULL
'.m	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIGURE	NULL
1	NULL
.	NULL

Okadaic	NULL
acid	NULL
prevents	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
PBL-T.	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
RNA	NULL
isolated	NULL
from	NULL
PBL-T	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
mitogenic	NULL
CD2	NULL
Abs	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
okadaic	NULL
acid	NULL
and	NULL
CD2	NULL
Abs	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
okadaic	NULL
acid	NULL
and	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
the	NULL
stimulating	NULL
agents	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
triggered	NULL
for	NULL
6	NULL
h.	NULL
Filters	NULL
were	NULL
hybridized	NULL
with	NULL
radioactively	NULL
labeled	NULL
cDNA	NULL
probes	NULL
for	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
and	NULL
the	NULL
B-actin	NULL
gene	NULL
.	NULL

between	NULL
these	NULL
possibilities	NULL
,	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
was	NULL
determined	NULL
in	NULL
nuclear	NULL
run-on	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
PBL-T	NULL
cells	NULL
were	NULL
activated	NULL
through	NULL
CD2	NULL
or	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
+	NULL
A23187	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
okadaic	NULL
acid	NULL
.	NULL

Both	NULL
CD2	NULL
triggering	NULL
and	NULL
PMA	NULL
+	NULL
A23187	NULL
treatment	NULL
induced	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
IL-2	NULL
)	NULL
,	NULL
which	NULL
was	NULL
inhibited	NULL
by	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
IL-2	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
general	NULL
down-regulation	NULL
of	NULL
transcriptional	NULL
processes	NULL
by	NULL
okadaic	NULL
acid	NULL
,	NULL
since	NULL
the	NULL
B-actin	NULL
gene	NULL
was	NULL
transcribed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
both	NULL
groups	NULL
of	NULL
differently	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B-actin	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factors	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
detectable	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
PBL-T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
was	NULL
even	NULL
strongly	NULL
induced	NULL
by	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
.	NULL

To	NULL
further	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
underlying	NULL
okadaic	NULL
acid-mediated	NULL
inhibition	NULL
of	NULL
IL-2	NULL
transcription	NULL
,	NULL
we	NULL
performed	NULL
IL-2	NULL
promoter	NULL
studies	NULL
using	NULL
transient	NULL
transfections	NULL
of	NULL
reporter	NULL
gene	NULL
constructs	NULL
or	NULL
the	NULL
in	NULL
vivo	NULL
footprinting	NULL
technique	NULL
.	NULL

Since	NULL
PBL-T	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
used	NULL
due	NULL
to	NULL
their	NULL
limited	NULL
experimental	NULL
manipulability	NULL
,	NULL
the	NULL
tumorigenic	NULL
murine	NULL
T	NULL
lymphoma	NULL
line	NULL
EL4	NULL
and	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
were	NULL
employed	NULL
.	NULL

As	NULL
shown	NULL
before	NULL
in	NULL
PBL-T	NULL
cells	NULL
,	NULL
the	NULL
high	NULL
level	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
detectable	NULL
in	NULL
PMA	NULL
+	NULL
A23187-activated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
c-fos	NULL
=	NULL
@	NULL
c-jun	NULL
#	NULL
-	NULL
©	NULL
'	NULL
o	NULL
§	NULL
89	NULL
6	NULL
&	NULL
ag	NULL
Lo	NULL
20	NULL
300	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIGURE	NULL
2	NULL
.	NULL

Okadaic	NULL
acid	NULL
blocks	NULL
IL-2	NULL
transcription	NULL
in	NULL
PBL-T	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
IL-2	NULL
,	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
B-actin	NULL
genes	NULL
in	NULL
PBL-T	NULL
was	NULL
determined	NULL
by	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

For	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
via	NULL
CD2	NULL
triggering	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
PMA/	NULL
A23187	NULL
treatment	NULL
(	NULL
Janes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
each	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Janes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
of	NULL
okadaic	NULL
acid	NULL
.	NULL

Okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

IL-2	NULL
,	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
B-actin	NULL
transcripts	NULL
were	NULL
detected	NULL
with	NULL
isolated	NULL
cDNA	NULL
probes	NULL
from	NULL
the	NULL
respective	NULL
genes	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
«	NULL
t	NULL
.	NULL

3	NULL
3	NULL
<	NULL
<	NULL
<	NULL
+	NULL
@	NULL
8	NULL
&	NULL
fe	NULL
x	NULL
#	NULL
£	NULL
t	NULL
S	NULL
&	NULL
m	NULL
IL-2	NULL
s*	NULL
|	NULL
ome	NULL
C	NULL
-acti	NULL
,	NULL
-actin	NULL
B	NULL
-actin	NULL
»	NULL
--	NULL
*	NULL
ap	NULL
B	NULL
6	NULL
_	NULL
*	NULL
m	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
17	NULL
8	NULL
Jurkat	NULL
EL-4	NULL
FIGURE	NULL
3	NULL
.	NULL

Okadaic	NULL
acid	NULL
inhibits	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
tumorigenic	NULL
cell	NULL
lines	NULL
Jurkat	NULL
and	NULL
EL4	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
RNA	NULL
isolated	NULL
from	NULL
differently	NULL
treated	NULL
Jurkat	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
or	NULL
ELA	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
5	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

For	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PMA/A23187	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
of	NULL
okadaic	NULL
acid	NULL
.	NULL

Okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
transcripts	NULL
,	NULL
cDNA	NULL
probes	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
Jurkat	NULL
cells	NULL
)	NULL
,	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
(	NULL
ELA	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
the	NULL
B-actin	NULL
gene	NULL
were	NULL
used	NULL
.	NULL

lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
was	NULL
not	NULL
induced	NULL
in	NULL
Jurkat	NULL
and	NULL
ELA	NULL
cells	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
okadaic	NULL
acid	NULL
on	NULL
IL-2	NULL
expression	NULL
are	NULL
independent	NULL
of	NULL
tumorigenic	NULL
transformation	NULL
and	NULL
the	NULL
differentiation	NULL
state	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

In	NULL
line	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
42	NULL
)	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
nonstimulated	NULL
EL4	NULL
cells	NULL
alone	NULL
induced	NULL
a	NULL
low	NULL
level	NULL
of	NULL
IL-2	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
seems	NULL
to	NULL
be	NULL
peculiar	NULL
to	NULL
ELA	NULL
cells	NULL
since	NULL
it	NULL
was	NULL
observed	NULL
neither	NULL
in	NULL
PBL-T	NULL
cells	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
nor	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Intriguingly	NULL
,	NULL
although	NULL
okadaic	NULL
acid	NULL
treatment	NULL
alone	NULL
induced	NULL
IL-2	NULL
expression	NULL
in	NULL
ELA	NULL
cells	NULL
,	NULL
this	NULL
compound	NULL
completely	NULL
prevented	NULL
IL-2	NULL
expression	NULL
in	NULL
ELA	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
upon	NULL
transient	NULL
transfection	NULL
of	NULL
EL4	NULL
cells	NULL
with	NULL
IL-2	NULL
promoter	NULL
reporter	NULL
constructs	NULL
,	NULL
in	NULL
which	NULL
the	NULL
luciferase	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
.	NULL

Two	NULL
IL-2	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
containing	NULL
either	NULL
the	NULL
321-bp	NULL
IL-2	NULL
enhancer	NULL
(	NULL
pmoIL2-321-luc	NULL
)	NULL
or	NULL
2-kb	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
pmoIL2-2k-luc	NULL
)	NULL
and	NULL
a	NULL
corresponding	NULL
control	NULL
vector	NULL
were	NULL
used	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
medium	NULL
(	NULL
-	NULL
)	NULL
,	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
P/A	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
three	NULL
agents	NULL
(	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
ELA	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
,	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
detected	NULL
,	NULL
which	NULL
were	NULL
not	NULL
altered	NULL
significantly	NULL
by	NULL
cell	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
vector	NULL
)	NULL
.	NULL

Irrespective	NULL
of	NULL
which	NULL
of	NULL
the	NULL
two	NULL
IL-2	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
was	NULL
transfected	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
-2k	NULL
,	NULL
-321	NULL
)	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
slightly	NULL
induced	NULL
by	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
OA	NULL
)	NULL
and	NULL
,	NULL
to	NULL
a	NULL
much	NULL
higher	NULL
level	NULL
,	NULL
by	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
P/A	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
okadaic	NULL
acid	NULL
completely	NULL
inhibited	NULL
the	NULL
PMA	NULL
+	NULL
A23187-inducible	NULL
activity	NULL
of	NULL
both	NULL
IL-2	NULL
promoter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
IL-2	NULL
transcription	NULL
in	NULL
transformed	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
in	NULL
primary	NULL
human	NULL
blood	NULL
T	NULL
cells	NULL
is	NULL
influenced	NULL
strongly	NULL
by	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
.	NULL

Okadaic	NULL
acid	NULL
inhibits	NULL
a	NULL
CsA-insensitive	NULL
pathway	NULL
of	NULL
IL-2	NULL
expression	NULL
Like	NULL
okadaic	NULL
acid	NULL
,	NULL
the	NULL
PP2B/calcineurin	NULL
inhibitor	NULL
CsA	NULL
prevents	NULL
IL-2	NULL
expression	NULL
via	NULL
a	NULL
transcriptional	NULL
block	NULL
(	NULL
43	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
blocking	NULL
activity	NULL
of	NULL
okadaic	NULL
acid	NULL
on	NULL
IL-2	NULL
tran	NULL
1805	NULL
&	NULL
ts	NULL
I	NULL
$	NULL
o	NULL
3	NULL
``	NULL
g	NULL
oa	NULL
9	NULL
3	NULL
P/A	NULL
E	NULL
C	NULL
200	NULL
§	NULL
P/A+0A	NULL
Z/f	NULL
J	NULL
35	NULL
100	NULL
at	NULL
§	NULL
O	NULL
IE	NULL
uttlt	NULL
/7/	NULL
'	NULL
vector	NULL
_-	NULL
-2k	NULL
«	NULL
321	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Okadaic	NULL
acid	NULL
prevents	NULL
IL-2	NULL
transcription	NULL
in	NULL
ELA	NULL
cells	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
00-luc	NULL
)	NULL
or	NULL
two	NULL
reporter	NULL
plasmids	NULL
expressing	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
fragments	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
.	NULL

-321-luc	NULL
contains	NULL
the	NULL
321	NULL
bp	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
,	NULL
and	NULL
-2k-luc	NULL
contains	NULL
the	NULL
2	NULL
kb	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
four	NULL
aliquots	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
-	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PMA/A23187	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
P/A	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
of	NULL
okadaic	NULL
acid	NULL
.	NULL

Okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
lysates	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
populations	NULL
were	NULL
measured	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
probe	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
normalized	NULL
luciferase	NULL
activities	NULL
expressed	NULL
as	NULL
multiples	NULL
of	NULL
the	NULL
value	NULL
measured	NULL
in	NULL
untreated	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
set	NULL
1	NULL
.	NULL

The	NULL
data	NULL
reflect	NULL
results	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
SE	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

scription	NULL
was	NULL
mediated	NULL
via	NULL
inhibition	NULL
of	NULL
PP2B/calcineurin	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
the	NULL
PP2B/calcineurin-independent	NULL
pathway	NULL
of	NULL
IL-2	NULL
expression	NULL
induced	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
the	NULL
activating	NULL
CD28	NULL
Ab	NULL
9.3	NULL
(	NULL
44	NULL
)	NULL
could	NULL
also	NULL
be	NULL
inhibited	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
point	NULL
,	NULL
a	NULL
Jurkat	NULL
cell	NULL
clone	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
IL-2	NULL
enhancer	NULL
luciferase	NULL
reporter	NULL
construct	NULL
pIL-2lucZkb	NULL
(	NULL
23	NULL
)	NULL
was	NULL
stimulated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
plus	NULL
CD28	NULL
Ab	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
an	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
while	NULL
treatment	NULL
with	NULL
each	NULL
agent	NULL
alone	NULL
led	NULL
to	NULL
no	NULL
significant	NULL
change	NULL
in	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
okadaic	NULL
acid	NULL
,	NULL
but	NULL
not	NULL
with	NULL
CsA	NULL
,	NULL
completely	NULL
abrogated	NULL
the	NULL
PMA/anti-CD28-inducible	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
luciferase	NULL
activity	NULL
,	NULL
induced	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
phorbolester	NULL
and	NULL
Ca	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
was	NULL
prevented	NULL
completely	NULL
by	NULL
both	NULL
okadaic	NULL
acid	NULL
and	NULL
CsA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
okadaic	NULL
acid	NULL
inhibits	NULL
a	NULL
PP2B/calcineurin-independent	NULL
pathway	NULL
involved	NULL
in	NULL
IL-2	NULL
expression	NULL
.	NULL

Oct-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
NF-AT-	NULL
,	NULL
but	NULL
not	NULL
AP-I-mediated	NULL
transcription	NULL
depends	NULL
on	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
To	NULL
determine	NULL
whether	NULL
okadaic	NULL
acid	NULL
differentially	NULL
influences	NULL
the	NULL
transactivation	NULL
by	NULL
individual	NULL
transcription	NULL
factors	NULL
regulating	NULL
IL-2	NULL
promoter	NULL
activity	NULL
,	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
multi-meric	NULL
NF-AT-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
or	NULL
Oct-binding	NULL
elements	NULL
derived	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
or	NULL
the	NULL
respective	NULL
control	NULL
vector	NULL
were	NULL
transfected	NULL
into	NULL
EL4	NULL
cells	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
P/A	NULL
)	NULL
,	NULL
or	NULL
okadaic	NULL
acid	NULL
and	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
EL4	NULL
cells	NULL
,	NULL
predominantly	NULL
the	NULL
Oct	NULL
reporter	NULL
was	NULL
stimulated	NULL
,	NULL
whereas	NULL
the	NULL
extent	NULL
of	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
NE-AT-reporter	NULL
induction	NULL
was	NULL
very	NULL
low	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
OA	NULL
)	NULL
.	NULL

PMA	NULL
+	NULL
A23187	NULL
treatment	NULL
activated	NULL
the	NULL
Oct-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
and	NULL
NE-AT-reporter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
P/A	NULL
)	NULL
,	NULL
while	NULL
application	NULL
of	NULL
okadaic	NULL
acid	NULL
inhibited	NULL
the	NULL
PMA	NULL
+	NULL
A23187-inducible	NULL
promoter	NULL
activities	NULL
of	NULL
all	NULL
three	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1806	NULL
160	NULL
158	NULL
156	NULL
relative	NULL
Luc	NULL
if	NULL
CTASE	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
oin	NULL
£	NULL
o	NULL
o	NULL
O	NULL
-_	NULL
OA	NULL
CsA	NULL
28	NULL
P	NULL
P/8	NULL
P/28	NULL
P/28	NULL
P/A	NULL
P/A	NULL
P/A	NULL
+o	NULL
+	NULL
+o	NULL
+	NULL
OA	NULL
CsA	NULL
OA	NULL
CsA	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
70	NULL
8	NULL
9	NULL
10	NULL
11	NULL
FIGURE	NULL
5	NULL
.	NULL

Okadaic	NULL
acid	NULL
inhibits	NULL
a	NULL
CsA-insensitive	NULL
pathway	NULL
of	NULL
IL-2	NULL
expression	NULL
.	NULL

Cells	NULL
from	NULL
the	NULL
Jurkat	NULL
clone	NULL
Jurkat-IL-2-luc	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
IL-2	NULL
promoter	NULL
reporter	NULL
construct	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
Zane	NULL
4	NULL
,	NULL
-	NULL
)	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
OA	NULL
)	NULL
,	NULL
CsA	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
CsA	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
P	NULL
)	NULL
,	NULL
the	NULL
CD28	NULL
Ab	NULL
9.3	NULL
(	NULL
lane	NULL
5	NULL
,	NULL
28	NULL
)	NULL
,	NULL
or	NULL
with	NULL
combinations	NULL
of	NULL
PMA	NULL
plus	NULL
CD28	NULL
Ab	NULL
(	NULL
lanes	NULL
6-8	NULL
,	NULL
P/28	NULL
)	NULL
or	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
lanes	NULL
9-11	NULL
,	NULL
P/A	NULL
)	NULL
.	NULL

Stimulations	NULL
via	NULL
P/28	NULL
or	NULL
P/A	NULL
treatment	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
OA	NULL
and	NULL
CsA	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
9	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OA	NULL
(	NULL
lane	NULL
7	NULL
,	NULL
P/28	NULL
+	NULL
OA	NULL
,	NULL
and	NULL
lane	NULL
10	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
or	NULL
CsA	NULL
(	NULL
lane	NULL
8	NULL
,	NULL
P/28	NULL
+	NULL
CsA	NULL
,	NULL
and	NULL
lane	NULL
11	NULL
,	NULL
P/A	NULL
+	NULL
CsA	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
and	NULL
CsA	NULL
were	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
triggered	NULL
for	NULL
6	NULL
h.	NULL
Luciferase	NULL
activities	NULL
of	NULL
lysates	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
populations	NULL
were	NULL
measured	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
probe	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
normalized	NULL
luciferase	NULL
activities	NULL
expressed	NULL
as	NULL
multiples	NULL
of	NULL
the	NULL
value	NULL
measured	NULL
in	NULL
untreated	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
set	NULL
1	NULL
.	NULL

The	NULL
data	NULL
reflect	NULL
results	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
SE	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

The	NULL
Oct	NULL
and	NULL
NF-AT	NULL
reporters	NULL
used	NULL
in	NULL
Figure	NULL
6A	NULL
contain	NULL
the	NULL
composite	NULL
binding	NULL
elements	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
that	NULL
allow	NULL
recruitment	NULL
of	NULL
AP-1	NULL
proteins	NULL
together	NULL
with	NULL
Oct	NULL
and	NULL
NF-AT	NULL
proteins	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
Oct-	NULL
and	NULL
AP-1-dependent	NULL
transcription	NULL
was	NULL
analyzed	NULL
using	NULL
Oct-	NULL
and	NULL
AP-1-specific	NULL
reporter	NULL
constructs	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
Oct	NULL
reporter	NULL
used	NULL
contains	NULL
a	NULL
multimerized	NULL
octamer	NULL
motif	NULL
(	NULL
27	NULL
)	NULL
.	NULL

It	NULL
had	NULL
a	NULL
high	NULL
constitutive	NULL
activity	NULL
in	NULL
nonactivated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
-	NULL
)	NULL
that	NULL
was	NULL
not	NULL
further	NULL
inducible	NULL
by	NULL
PMA	NULL
+	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
P/A	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
strongly	NULL
reduced	NULL
this	NULL
activity	NULL
both	NULL
in	NULL
nonactivated	NULL
and	NULL
activated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
reporter	NULL
contains	NULL
a	NULL
multimerized	NULL
AP-1	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
reporter	NULL
was	NULL
induced	NULL
by	NULL
okadaic	NULL
acid	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
OA	NULL
)	NULL
or	NULL
PMA	NULL
+	NULL
A23187	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
P/A	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
the	NULL
Oct-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
and	NULL
NF-AT-reporter	NULL
constructs	NULL
,	NULL
simultaneous	NULL
addition	NULL
of	NULL
okadaic	NULL
acid	NULL
and	NULL
PMA	NULL
+	NULL
A23187	NULL
further	NULL
enhanced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
imply	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
Oct	NULL
and	NULL
NF-AT	NULL
reporters	NULL
derived	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
is	NULL
mediated	NULL
by	NULL
repression	NULL
of	NULL
Oct	NULL
and	NULL
NF-AT	NULL
activity	NULL
,	NULL
and	NULL
not	NULL
by	NULL
inhibition	NULL
of	NULL
AP-1	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
occupancy	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
EL4	NULL
cells	NULL
To	NULL
analyze	NULL
the	NULL
events	NULL
at	NULL
the	NULL
endogenous	NULL
IL-2	NULL
promoter	NULL
that	NULL
are	NULL
influenced	NULL
by	NULL
okadaic	NULL
acid	NULL
treatment	NULL
,	NULL
we	NULL
used	NULL
the	NULL
in	NULL
vivo	NULL
footprinting	NULL
technique	NULL
by	NULL
which	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
intact	NULL
cells	NULL
can	NULL
be	NULL
visualized	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
ELA	NULL
cells	NULL
were	NULL
treated	NULL
in	NULL
culture	NULL
with	NULL
the	NULL
membrane-permeable	NULL
alkylating	NULL
agent	NULL
DMS	NULL
.	NULL

After	NULL
DMS	NULL
treatment	NULL
,	NULL
piperidine	NULL
was	NULL
used	NULL
to	NULL
produce	NULL
DNA	NULL
cleavage	NULL
at	NULL
alkylated	NULL
G	NULL
residues	NULL
.	NULL

Resulting	NULL
fragments	NULL
spanning	NULL
the	NULL
IL-2	NULL
promoter	NULL
region	NULL
were	NULL
visualized	NULL
by	NULL
the	NULL
ligation-mediated	NULL
PCR	NULL
OKADAIC	NULL
ACID-SENSITIVE	NULL
PHOSPHATASES	NULL
REGULATE	NULL
IL-2	NULL
EXPRESSION	NULL
technique	NULL
(	NULL
47	NULL
)	NULL
,	NULL
giving	NULL
a	NULL
G-specific	NULL
sequence	NULL
ladder	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

DMS	NULL
footprints	NULL
(	NULL
ie	NULL
.	NULL

,	NULL
protected	NULL
or	NULL
hypersensitive	NULL
G	NULL
resi-dues	NULL
)	NULL
indicative	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
were	NULL
revealed	NULL
by	NULL
comparing	NULL
the	NULL
patterns	NULL
of	NULL
G-specific	NULL
sequence	NULL
ladders	NULL
obtained	NULL
from	NULL
differently	NULL
stimulated	NULL
living	NULL
EL4	NULL
cell	NULL
populations	NULL
with	NULL
those	NULL
obtained	NULL
from	NULL
purified	NULL
and	NULL
in	NULL
vitro	NULL
methylated	NULL
genomic	NULL
DNA	NULL
of	NULL
ELA	NULL
cells	NULL
.	NULL

PMA	NULL
+	NULL
A23187	NULL
treatment	NULL
of	NULL
EL4	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
change	NULL
of	NULL
the	NULL
pattern	NULL
of	NULL
the	NULL
G-specific	NULL
sequence	NULL
ladder	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
one	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Footprints	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
reproducible	NULL
changes	NULL
of	NULL
band	NULL
intensities	NULL
of	NULL
at	NULL
least	NULL
25	NULL
%	NULL
)	NULL
,	NULL
as	NULL
described	NULL
before	NULL
(	NULL
36	NULL
)	NULL
,	NULL
were	NULL
visible	NULL
within	NULL
the	NULL
coding	NULL
strand	NULL
at	NULL
the	NULL
Oct	NULL
site	NULL
(	NULL
protection	NULL
at	NULL
G	NULL
``	NULL
``	NULL
)	NULL
,	NULL
the	NULL
OAP	NULL
site	NULL
(	NULL
protection	NULL
at	NULL
G	NULL
**	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
NF-AT	NULL
site	NULL
(	NULL
protection	NULL
at	NULL
G	NULL
_*'*°	NULL
and	NULL
hypersensitivity	NULL
at	NULL
G	NULL
'*	NULL
)	NULL
,	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
hy-persensitivities	NULL
at	NULL
G_'*	NULL
>	NULL
and	NULL
G	NULL
'	NULL
``	NULL
)	NULL
,	NULL
the	NULL
ATGG	NULL
site	NULL
(	NULL
protections	NULL
at	NULL
G	NULL
~*	NULL
``	NULL
and	NULL
G	NULL
***	NULL
)	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
protections	NULL
at	NULL
G	NULL
and	NULL
G*	NULL
``	NULL
)	NULL
,	NULL
the	NULL
TGGGC	NULL
site	NULL
(	NULL
protections	NULL
at	NULL
G	NULL
***	NULL
and	NULL
G	NULL
~*	NULL
``	NULL
)	NULL
,	NULL
and	NULL
the	NULL
distal	NULL
NF-AT	NULL
site	NULL
(	NULL
protection	NULL
at	NULL
G~_**	NULL
>	NULL
and	NULL
hypersensitivity	NULL
at	NULL
G	NULL
**	NULL
``	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
of	NULL
EL4	NULL
cells	NULL
alone	NULL
reproducibly	NULL
induced	NULL
a	NULL
protection	NULL
at	NULL
G	NULL
``	NULL
'	NULL
within	NULL
the	NULL
Oct	NULL
site	NULL
,	NULL
at	NULL
G	NULL
**	NULL
within	NULL
the	NULL
OAP	NULL
site	NULL
,	NULL
and	NULL
two	NULL
hypersensitivities	NULL
at	NULL
G	NULL
~	NULL
'	NULL
and	NULL
G~_'**	NULL
indicative	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
IL-2	NULL
expression	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Ref	NULL
.	NULL

42	NULL
)	NULL
as	NULL
well	NULL
as	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
expression	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
activity	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
binding	NULL
of	NULL
Oct	NULL
and	NULL
AP-1	NULL
proteins	NULL
seemed	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
induce	NULL
a	NULL
low	NULL
level	NULL
of	NULL
IL-2	NULL
transcription	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
+	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
okadaic	NULL
acid	NULL
showed	NULL
no	NULL
footprints	NULL
at	NULL
all	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
PMA	NULL
+	NULL
A23187	NULL
plus	NULL
okadaic	NULL
acid-treated	NULL
ELA	NULL
cells	NULL
also	NULL
AP-1	NULL
proteins	NULL
,	NULL
although	NULL
activated	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
P/A	NULL
+	NULL
OA	NULL
)	NULL
,	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
footprints	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
gene	NULL
specific	NULL
since	NULL
the	NULL
cellular	NULL
c-fos	NULL
promoter	NULL
was	NULL
still	NULL
occupied	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
same	NULL
DNA	NULL
preparations	NULL
,	NULL
as	NULL
used	NULL
for	NULL
the	NULL
IL-2	NULL
promoter	NULL
analysis	NULL
,	NULL
revealed	NULL
the	NULL
characteristic	NULL
footprint	NULL
pattern	NULL
at	NULL
the	NULL
SRE	NULL
binding	NULL
region	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
37	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
okadaic	NULL
acid	NULL
completely	NULL
prevents	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
PMA	NULL
+	NULL
A23187-stimulated	NULL
EL4	NULL
cells	NULL
.	NULL

Discussion	NULL
IL-2	NULL
is	NULL
produced	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Its	NULL
expression	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
posttranscriptional	NULL
effects	NULL
on	NULL
IL-2	NULL
mRNA	NULL
stability	NULL
have	NULL
been	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
it	NULL
is	NULL
demonstrated	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
inhibitor	NULL
of	NULL
Ser/Thr	NULL
phosphatases	NULL
of	NULL
the	NULL
subfamilies	NULL
1	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
5	NULL
,	NULL
okadaic	NULL
acid	NULL
,	NULL
prevents	NULL
IL-2	NULL
expression	NULL
through	NULL
a	NULL
transcriptional	NULL
block	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
caused	NULL
no	NULL
general	NULL
inhibition	NULL
of	NULL
transcription	NULL
since	NULL
the	NULL
B-actin	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
c-jun	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
AP-1-dependent	NULL
reporter	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
were	NULL
still	NULL
transcribed	NULL
.	NULL

There-fore	NULL
,	NULL
neither	NULL
RNA	NULL
polymerase	NULL
II	NULL
nor	NULL
the	NULL
basic	NULL
transcriptional	NULL
machinery	NULL
is	NULL
affected	NULL
directly	NULL
by	NULL
inhibition	NULL
of	NULL
these	NULL
Ser/Thr	NULL
phosphatases	NULL
.	NULL

Interestingly	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
differentially	NULL
affects	NULL
the	NULL
po-tencies	NULL
of	NULL
individual	NULL
transcription	NULL
factors	NULL
regulating	NULL
IL-2	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
okadaic	NULL
acid	NULL
inhibits	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
Oct-	NULL
,	NULL
and	NULL
NF-AT-mediated	NULL
transactivation	NULL
processes	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
AP-1	NULL
activity	NULL
is	NULL
even	NULL
enhanced	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
1807	NULL
relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
vector	NULL
Oct	NULL
(	NULL
IL-2	NULL
)	NULL
relative	NULL
lucif	NULL
erase	NULL
activity	NULL
w	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
(	NULL
IL-2	NULL
)	NULL
H	NULL
M	NULL
OA	NULL
P/A	NULL
§	NULL
P/A+0A	NULL
NFAT	NULL
(	NULL
IL-2	NULL
)	NULL
relative	NULL
CAT	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
vector	NULL
FIGURE	NULL
6	NULL
.	NULL

Okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
differentially	NULL
influence	NULL
individual	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
,	NULL
ELA	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter	NULL
constructs	NULL
containing	NULL
multimerized	NULL
Oct-	NULL
,	NULL
NF-B-	NULL
,	NULL
or	NULL
NF-AT-binding	NULL
elements	NULL
derived	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
or	NULL
a	NULL
control	NULL
vector	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
and	NULL
determination	NULL
of	NULL
luciferase	NULL
activities	NULL
were	NULL
performed	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
.	NULL

B	NULL
,	NULL
For	NULL
analysis	NULL
of	NULL
Oct-specific	NULL
transactivation	NULL
,	NULL
the	NULL
Oct-reporter	NULL
4X	NULL
oct-luc	NULL
containing	NULL
a	NULL
multimerized	NULL
Oct	NULL
consensus	NULL
site	NULL
(	NULL
Oct	NULL
(	NULL
cons	NULL
.	NULL
)	NULL

)	NULL
was	NULL
transfected	NULL
into	NULL
ELA	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

C	NULL
,	NULL
EL4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
AP-1	NULL
reporter	NULL
5X	NULL
TRE-TATA-CAT	NULL
containing	NULL
the	NULL
AP-1	NULL
site	NULL
from	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
(	NULL
AP-1	NULL
(	NULL
coll	NULL
.	NULL
)	NULL

)	NULL
or	NULL
a	NULL
control	NULL
vector	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
before	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
in	NULL
lysates	NULL
of	NULL
the	NULL
different	NULL
cell	NULL
populations	NULL
were	NULL
determined	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
probe	NULL
.	NULL

In	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
and	NULL
untreated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
AP-1	NULL
reporter	NULL
,	NULL
no	NULL
CAT	NULL
activities	NULL
were	NULL
detected	NULL
.	NULL

The	NULL
normalized	NULL
CAT	NULL
activities	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
populations	NULL
are	NULL
therefore	NULL
shown	NULL
as	NULL
multiples	NULL
of	NULL
the	NULL
value	NULL
measured	NULL
in	NULL
P/A-activated	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
set	NULL
1	NULL
.	NULL

The	NULL
data	NULL
reflect	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
SE	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
enhances	NULL
AP-1	NULL
activity	NULL
through	NULL
an	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
AP-1	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
see	NULL
also	NULL
Ref	NULL
.	NULL

49	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
this	NULL
AP-1	NULL
expression	NULL
was	NULL
still	NULL
detectable	NULL
at	NULL
late	NULL
times	NULL
after	NULL
activation	NULL
.	NULL

In	NULL
both	NULL
activated	NULL
and	NULL
nonactivated	NULL
PBL-T	NULL
cells	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
high	NULL
transcription	NULL
rate	NULL
of	NULL
AP-1	NULL
genes	NULL
6	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Okadaic	NULL
acid	NULL
treatment	NULL
rapidly	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
AP-1	NULL
genes	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
junD	NULL
in	NULL
ELA	NULL
cells	NULL
.	NULL

This	NULL
expression	NULL
was	NULL
still	NULL
detectable	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

This	NULL
kinetics	NULL
of	NULL
the	NULL
AP-1	NULL
expression	NULL
differs	NULL
from	NULL
that	NULL
under	NULL
other	NULL
experimental	NULL
conditions	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
in	NULL
which	NULL
AP-1	NULL
expression	NULL
occurs	NULL
as	NULL
an	NULL
early	NULL
event	NULL
followed	NULL
by	NULL
a	NULL
rapid	NULL
shut-off	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

9	NULL
for	NULL
summary	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
shut-off	NULL
is	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
the	NULL
AP-1	NULL
expression	NULL
pattern	NULL
in	NULL
T	NULL
cells	NULL
described	NULL
in	NULL
this	NULL
study	NULL
could	NULL
be	NULL
that	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
AP-1	NULL
expression	NULL
.	NULL

In	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
IL-2	NULL
transcription	NULL
was	NULL
inhibited	NULL
completely	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

AP-1	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
enhanced	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
was	NULL
clearly	NULL
not	NULL
sufficient	NULL
to	NULL
overcome	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
okadaic	NULL
acid	NULL
on	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

This	NULL
could	NULL
be	NULL
based	NULL
on	NULL
the	NULL
finding	NULL
that	NULL
IL-2	NULL
transcription	NULL
seems	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
complete	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
,	NULL
most	NULL
likely	NULL
because	NULL
the	NULL
IL-2	NULL
promoter	NULL
contains	NULL
nonconsensus	NULL
binding	NULL
sites	NULL
that	NULL
favor	NULL
cooperative	NULL
transcription	NULL
factor	NULL
binding	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
AP-1	NULL
proteins	NULL
,	NULL
although	NULL
induced	NULL
,	NULL
could	NULL
not	NULL
transactivate	NULL
the	NULL
IL-2	NULL
promoter	NULL
because	NULL
their	NULL
binding	NULL
affinities	NULL
toward	NULL
the	NULL
nonconsensus	NULL
AP-1-binding	NULL
elements	NULL
would	NULL
not	NULL
be	NULL
strong	NULL
enough	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
Oct	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
NF-AT	NULL
activities	NULL
are	NULL
missing	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
okadaic	NULL
acid-treated	NULL
EL4	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
+	NULL
A23187	NULL
is	NULL
not	NULL
occupied	NULL
,	NULL
indicating	NULL
that	NULL
transcription	NULL
was	NULL
blocked	NULL
due	NULL
to	NULL
complete	NULL
inhibition	NULL
of	NULL
activator	NULL
binding	NULL
.	NULL

Moreover	NULL
,	NULL
no	NULL
evidence	NULL
for	NULL
binding	NULL
of	NULL
repressor	NULL
proteins	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
found	NULL
.	NULL

In	NULL
nonactivated	NULL
ELA	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
led	NULL
to	NULL
low	NULL
expression	NULL
of	NULL
IL-2	NULL
.	NULL

Note	NULL
that	NULL
this	NULL
was	NULL
the	NULL
case	NULL
only	NULL
in	NULL
EL4	NULL
cells	NULL
,	NULL
not	NULL
in	NULL
the	NULL
other	NULL
transformed	NULL
and	NULL
nontransformed	NULL
T	NULL
cells	NULL
analyzed	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Okadaic	NULL
acid-induced	NULL
IL-2	NULL
expression	NULL
in	NULL
ELA	NULL
cells	NULL
correlated	NULL
with	NULL
footprints	NULL
only	NULL
at	NULL
the	NULL
Oct	NULL
site	NULL
at	NULL
the	NULL
noncomposite	NULL
AP-1	NULL
site	NULL
at	NULL
nucleotides	NULL
G	NULL
'	NULL
``	NULL
and	NULL
G~'**	NULL
,	NULL
and	NULL
at	NULL
the	NULL
OAP	NULL
site	NULL
that	NULL
is	NULL
bound	NULL
by	NULL
AP-1	NULL
proteins	NULL
(	NULL
46	NULL
)	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
nonactivated	NULL
ELA	NULL
cells	NULL
,	NULL
Oct	NULL
and	NULL
AP-1	NULL
proteins	NULL
can	NULL
induce	NULL
transcription	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

One	NULL
possibility	NULL
to	NULL
explain	NULL
the	NULL
opposite	NULL
effects	NULL
of	NULL
okadaic	NULL
acid	NULL
on	NULL
IL-2	NULL
transcription	NULL
in	NULL
activated	NULL
and	NULL
nonactivated	NULL
ELA	NULL
cells	NULL
could	NULL
be	NULL
that	NULL
the	NULL
accessibility	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
different	NULL
.	NULL

Since	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
proteins	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
is	NULL
distinct	NULL
in	NULL
activated	NULL
and	NULL
nonactivated	NULL
ELA	NULL
cells	NULL
while	NULL
transactivating	NULL
capacities	NULL
of	NULL
AP1	NULL
proteins	NULL
are	NULL
detectable	NULL
in	NULL
both	NULL
states	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
perhaps	NULL
this	NULL
means	NULL
that	NULL
,	NULL
comparable	NULL
with	NULL
the	NULL
situation	NULL
that	NULL
is	NULL
found	NULL
at	NULL
a	NULL
growing	NULL
number	NULL
of	NULL
cellular	NULL
promoters	NULL
(	NULL
50	NULL
,	NULL
51	NULL
)	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1808	NULL
OKADAIC	NULL
ACID-SENSITIVE	NULL
PHOSPHATASES	NULL
REGULATE	NULL
IL-2	NULL
EXPRESSION	NULL
in	NULL
vivo	NULL
2,5	NULL
He	NULL
DMS	NULL
S	NULL
p-	NULL
2	NULL
fn	NULL
<	NULL
1,5	NULL
o	NULL
[	NULL
a	NULL
»	NULL
)	NULL
'S	NULL
a	NULL
<	NULL
a	NULL
%	NULL
&	NULL
.	NULL

6	NULL
&	NULL
&	NULL
t	NULL
°~~	NULL
-	NULL
1G6GGC	NULL
G-225	NULL
,	NULL
G22	NULL
2,5	NULL
==	NULL
NFAT	NULL
*	NULL
a	NULL
1,5	NULL
-250	NULL
j	NULL
\	NULL
%	NULL
0,5	NULL
/	NULL
#	NULL
34	NULL
&	NULL
#	NULL
I	NULL
HR	NULL
|	NULL
mage	NULL
TGGGC	NULL
0	NULL
/	NULL
b	NULL
NFKB	NULL
ATGG	NULL
a	NULL
wa	NULL
HB	NULL
in	NULL
as	NULL
|	NULL
=	NULL
NF	NULL
xB	NULL
/	NULL
6-207	NULL
,	NULL
G-206	NULL
,	NULL
G-205	NULL
_	NULL
G-174	NULL
,	NULL
G-173	NULL
-200	NULL
2,5	NULL
M	NULL
--	NULL
t	NULL
bo	NULL
di-	NULL
2	NULL
@	NULL
W	NULL
®	NULL
m	NULL
a|=-=	NULL
ATGG	NULL
1,5	NULL
A	NULL
1	NULL
150	NULL
i	NULL
I	NULL
8	NULL
a	NULL
=	NULL
|=	NULL
@	NULL
API	NULL
--	NULL
-	NULL
>	NULL
»	NULL
0,5	NULL
-	NULL
F	NULL
0	NULL
a	NULL
a	NULL
8	NULL
=	NULL
&	NULL
|==*	NULL
NFAT	NULL
haes	NULL
Bis	NULL
:	NULL
m	NULL
a	NULL
#	NULL
t	NULL
a	NULL
100	NULL
]	NULL
§	NULL
C	NULL
C	NULL
2	NULL
S8	NULL
8	NULL
»	NULL
®	NULL
=	NULL
NFAT	NULL
NFAT	NULL
G-140	NULL
G-138	NULL
``	NULL
%	NULL
&	NULL
B	NULL
%	NULL
oap	NULL
28	NULL
2	NULL
-	NULL
@	NULL
-	NULL
-	NULL
-	NULL
|	NULL
--	NULL
OCT	NULL
\	NULL
1,5	NULL
1	NULL
i	NULL
&	NULL
#	NULL
6	NULL
«	NULL
0,5	NULL
/	NULL
,	NULL
o	NULL
f	NULL
OAP	NULL
oCtT	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
G44	NULL
67	NULL
FIGURE	NULL
7	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
occupancy	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
ELA	NULL
cells	NULL
.	NULL

In	NULL
vivo	NULL
methylated	NULL
genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
from	NULL
EL4	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
(	NULL
Zane	NULL
2	NULL
,	NULL
black	NULL
bars	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
okadaic	NULL
acid	NULL
(	NULL
Jane	NULL
3	NULL
,	NULL
bars	NULL
striped	NULL
longitudinal	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
PMA/A23187	NULL
for	NULL
6	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
bars	NULL
striped	NULL
diagonal	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Zane	NULL
5	NULL
,	NULL
cross-striped	NULL
bars	NULL
)	NULL
of	NULL
okadaic	NULL
acid	NULL
.	NULL

Okadaic	NULL
acid	NULL
was	NULL
added	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

The	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
footprinted	NULL
from	NULL
in	NULL
vivo	NULL
methylated	NULL
DNA	NULL
preparations	NULL
(	NULL
Zanes	NULL
2-5	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
from	NULL
untreated	NULL
ELA	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
,	NULL
bars	NULL
shaded	NULL
)	NULL
using	NULL
the	NULL
ligation-mediated	NULL
PCR	NULL
protocol	NULL
.	NULL

The	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
repetitions	NULL
.	NULL

On	NULL
the	NULL
Zeft	NULL
,	NULL
nucleotide	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
point	NULL
are	NULL
shown	NULL
.	NULL

In	NULL
the	NULL
middle	NULL
,	NULL
hypersensitivities	NULL
(	NULL
open	NULL
arrows	NULL
)	NULL
and	NULL
protections	NULL
(	NULL
filled	NULL
arrows	NULL
)	NULL
that	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
occur	NULL
at	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
corresponding	NULL
binding	NULL
transcription	NULL
factors	NULL
(	NULL
NF-AT	NULL
,	NULL
TGGGC	NULL
,	NULL
NF-KB	NULL
,	NULL
ATGG	NULL
,	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
,	NULL
OAP	NULL
,	NULL
Oct	NULL
)	NULL
are	NULL
marked	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
autoradiogram	NULL
is	NULL
presented	NULL
on	NULL
the	NULL
right-hand	NULL
side	NULL
.	NULL

Relative	NULL
intensity	NULL
values	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
determined	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

For	NULL
graph	NULL
representation	NULL
,	NULL
relative	NULL
intensity	NULL
values	NULL
derived	NULL
from	NULL
in	NULL
vivo	NULL
methylated	NULL
DNAs	NULL
were	NULL
normalized	NULL
to	NULL
that	NULL
from	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
,	NULL
which	NULL
was	NULL
set	NULL
1	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
protected	NULL
G	NULL
***	NULL
and	NULL
the	NULL
hypersensitive	NULL
G	NULL
**	NULL
``	NULL
at	NULL
the	NULL
distal	NULL
NF-AT	NULL
site	NULL
was	NULL
impaired	NULL
by	NULL
the	NULL
weak	NULL
resolution	NULL
on	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

the	NULL
IL-2	NULL
promoter	NULL
is	NULL
regulated	NULL
by	NULL
its	NULL
nucleosomal	NULL
architecture	NULL
as	NULL
well	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
would	NULL
induce	NULL
the	NULL
establishment	NULL
or	NULL
fixes	NULL
(	NULL
in	NULL
other	NULL
T	NULL
cells	NULL
)	NULL
a	NULL
promoter	NULL
structure	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
that	NULL
does	NULL
not	NULL
permit	NULL
access	NULL
of	NULL
single	NULL
transcription	NULL
of	NULL
an	NULL
open	NULL
form	NULL
of	NULL
IL-2	NULL
promoter	NULL
packaging	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
during	NULL
activation	NULL
may	NULL
either	NULL
alter	NULL
or	NULL
disturb	NULL
this	NULL
process	NULL
.	NULL

At	NULL
present	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
,	NULL
and	NULL
if	NULL
so	NULL
how	NULL
,	NULL
okadaic	NULL
acid	NULL
treatment	NULL
induces	NULL
(	NULL
in	NULL
activated	NULL
ELA	NULL
cells	NULL
)	NULL
factors	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
simultaneous	NULL
cell	NULL
activation	NULL
and	NULL
okadaic	NULL
acid	NULL
treatment	NULL
may	NULL
establish	NULL
a	NULL
new	NULL
inhibitory	NULL
form	NULL
of	NULL
IL-2	NULL
promoter	NULL
packaging	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
characteristic	NULL
features	NULL
of	NULL
IL-2	NULL
transcription	NULL
in	NULL
ELA	NULL
cells	NULL
indicate	NULL
that	NULL
besides	NULL
transcription	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
factor	NULL
activity	NULL
,	NULL
changes	NULL
of	NULL
the	NULL
chromatin	NULL
structure	NULL
are	NULL
probably	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
signaling	NULL
pathway	NULL
investigated	NULL
in	NULL
this	NULL
study	NULL
does	NULL
not	NULL
involve	NULL
PP2B/calcineurin	NULL
.	NULL

Thus	NULL
,	NULL
inhibition	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
abrogated	NULL
both	NULL
the	NULL
PP2B/calcineurin-depen-dent	NULL
and	NULL
independent	NULL
pathways	NULL
of	NULL
IL-2	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
similarities	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
okadaic	NULL
acid	NULL
and	NULL
the	NULL
PP2B/calcineurin	NULL
inhibitor	NULL
CsA	NULL
are	NULL
,	NULL
however	NULL
,	NULL
remarkable	NULL
:	NULL
loss	NULL
of	NULL
activator	NULL
binding	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
36	NULL
)	NULL
.	NULL

CsA	NULL
is	NULL
known	NULL
to	NULL
block	NULL
NFE-AT	NULL
activation	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
to	NULL
exert	NULL
inhibitory	NULL
effects	NULL
on	NULL
Oct	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
(	NULL
17	NULL
,	NULL
46	NULL
,	NULL
52	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
,	NULL
okadaic	NULL
acid	NULL
also	NULL
inhibits	NULL
NF-AT	NULL
,	NULL
Oct	NULL
,	NULL
and	NULL
NF-KB	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

One	NULL
conclusion	NULL
from	NULL
these	NULL
observations	NULL
is	NULL
to	NULL
predict	NULL
a	NULL
convergence	NULL
of	NULL
the	NULL
pathways	NULL
depending	NULL
on	NULL
okadaic	NULL
acid-sensitive	NULL
Ser/Thr	NULL
phosphatases	NULL
and	NULL
on	NULL
PP2B/calcineurin	NULL
.	NULL

Perhaps	NULL
this	NULL
occurs	NULL
downstream	NULL
of	NULL
PP2B/calcineurin	NULL
,	NULL
since	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
PP2B/	NULL
calcineurin	NULL
may	NULL
activate	NULL
the	NULL
type	NULL
1	NULL
Ser/Thr	NULL
phosphatase	NULL
PPI	NULL
by	NULL
inactivation	NULL
of	NULL
the	NULL
PP1	NULL
inhibitor	NULL
1	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
dependency	NULL
of	NULL
IL-2	NULL
transcription	NULL
on	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
is	NULL
conserved	NULL
during	NULL
tumorigenic	NULL
transformation	NULL
and	NULL
evolution	NULL
,	NULL
since	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
okadaic	NULL
acid	NULL
was	NULL
observed	NULL
in	NULL
nontransformed	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
malignant	NULL
T	NULL
cell	NULL
lines	NULL
from	NULL
mice	NULL
and	NULL
humans	NULL
.	NULL

This	NULL
stresses	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
phosphatases	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
expression	NULL
.	NULL

Future	NULL
work	NULL
should	NULL
focus	NULL
on	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
individual	NULL
phosphatases	NULL
and	NULL
proteins	NULL
targeted	NULL
by	NULL
them	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
essential	NULL
actin-binding	NULL
protein	NULL
pp19/cofilin	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
one	NULL
of	NULL
the	NULL
substrates	NULL
of	NULL
okadaic	NULL
acid-sensitive	NULL
phosphatases	NULL
.	NULL

Dephosphoryla-tion	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
pp19/cofilin	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
costimulatory	NULL
signals	NULL
correlate	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
production	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Whether	NULL
effects	NULL
of	NULL
cofilin	NULL
on	NULL
the	NULL
nucleoskeleton	NULL
are	NULL
involved	NULL
in	NULL
changes	NULL
of	NULL
the	NULL
chromatin	NULL
structure	NULL
influencing	NULL
transcriptional	NULL
activation	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
H.	NULL
Kirchgessner	NULL
and	NULL
B.	NULL
Schraven	NULL
for	NULL
the	NULL
Jurkat	NULL
clone	NULL
IL-2-luc	NULL
,	NULL
T.	NULL
Tsuruta	NULL
and	NULL
T.	NULL
Yokota	NULL
for	NULL
the	NULL
IL-2	NULL
promoter	NULL
reporter	NULL
constructs	NULL
,	NULL
P.	NULL
Quehl	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
CD2	NULL
antibodies	NULL
,	NULL
and	NULL
H.	NULL
Kénig	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Robey	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1995	NULL
.	NULL

T-cell	NULL
activation	NULL
:	NULL
integration	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
antigen	NULL
receptor	NULL
and	NULL
costimulatory	NULL
molecules	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
16:306	NULL
.	NULL

2	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1989	NULL
.	NULL

Clonal	NULL
expansion	NULL
vs	NULL
functional	NULL
clonal	NULL
inactivation	NULL
:	NULL
a	NULL
costimulatory	NULL
signalling	NULL
pathway	NULL
determines	NULL
the	NULL
outcome	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
occupancy	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:445	NULL
.	NULL

3	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
R.	NULL
Kingston	NULL
,	NULL
E.	NULL
J.	NULL
Jenkinson	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
T.	NULL
Owen	NULL
.	NULL

1989	NULL
.	NULL

Antibodies	NULL
to	NULL
CD3/T-cell	NULL
receptor	NULL
complex	NULL
induce	NULL
death	NULL
by	NULL
apoptosis	NULL
in	NULL
immature	NULL
T	NULL
cells	NULL
in	NULL
thymic	NULL
cultures	NULL
.	NULL

Nature	NULL
337:181	NULL
.	NULL

4	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
McArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
H.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

CD28-mediated	NULL
signalling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T-cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607	NULL
.	NULL

5	NULL
.	NULL

Gimmi	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
J.	NULL
G.	NULL
Gribben	NULL
,	NULL
G.	NULL
Gray	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
T-cell	NULL
clonal	NULL
anergy	NULL
is	NULL
induced	NULL
by	NULL
antigen	NULL
presentation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B7	NULL
costimulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:6586	NULL
.	NULL

6	NULL
.	NULL

Samstag	NULL
,	NULL
Y.	NULL
,	NULL
A.	NULL
Bader	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
serine	NULL
phosphatase	NULL
is	NULL
involved	NULL
in	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:788	NULL
.	NULL

7	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:321	NULL
.	NULL

8	NULL
.	NULL

Crabiree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045	NULL
.	NULL

9	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333	NULL
.	NULL

10	NULL
.	NULL

Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
C.	NULL
Tran	NULL
,	NULL
M.	NULL
Grilli	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:1452	NULL
.	NULL

11	NULL
.	NULL

Lederer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
S.	NULL
Liou	NULL
,	NULL
M.	NULL
D.	NULL
Todd	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
A.	NULL
H.	NULL
Lichtman	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
subsets	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:77	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

1809	NULL
Williams	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
M.	NULL
Woodrow	NULL
,	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Murray	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
is	NULL
not	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:42	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
lesson	NULL
in	NULL
family	NULL
values	NULL
.	NULL

Cell	NULL
80	NULL
:	NULL
529	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
phosphory-lation	NULL
.	NULL

Cell	NULL
70:375	NULL
.	NULL

Marais	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SRF	NULL
accessory	NULL
protein	NULL
Elk-1	NULL
contains	NULL
a	NULL
growth	NULL
factor-regulated	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
73:381	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben	NULL
Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352:803	NULL
.	NULL

Loh	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
T.	NULL
Shaw	NULL
,	NULL
J.	NULL
Carew	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Calcineurin	NULL
binds	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
and	NULL
reversibly	NULL
regulates	NULL
its	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:10884	NULL
.	NULL

Shibasaki	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
R.	NULL
Price	NULL
,	NULL
D.	NULL
Milan	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
kinases	NULL
and	NULL
the	NULL
phosphatase	NULL
calcineurin	NULL
in	NULL
the	NULL
nuclear	NULL
shuttling	NULL
of	NULL
transcription	NULL
factor	NULL
NF-AT4	NULL
.	NULL

Nature	NULL
382:370	NULL
.	NULL

Samstag	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
W.	NULL
Henning	NULL
,	NULL
A.	NULL
Bader	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1992	NULL
.	NULL

Dephosphoryla-tion	NULL
of	NULL
pp19	NULL
:	NULL
a	NULL
common	NULL
second	NULL
signal	NULL
for	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
mediated	NULL
through	NULL
different	NULL
accessory	NULL
molecules	NULL
.	NULL

Inf	NULL
.	NULL

Immunol	NULL
.	NULL

4:1255	NULL
.	NULL

Samstag	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Eckerskorn	NULL
,	NULL
S.	NULL
Wesselborg	NULL
,	NULL
S.	NULL
Henning	NULL
,	NULL
R.	NULL
Wallich	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1994	NULL
.	NULL

Costimulatory	NULL
signals	NULL
for	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
induce	NULL
nuclear	NULL
translocation	NULL
of	NULL
pp19/cofilin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:4494	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
T.	NULL
1997	NULL
.	NULL

Novel	NULL
protein	NULL
serine/threonine	NULL
phosphatases	NULL
:	NULL
variety	NULL
is	NULL
the	NULL
spice	NULL
of	NULL
life	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

22:245	NULL
.	NULL

Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
S.	NULL
E.	NULL
Ross	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
L.	NULL
R.	NULL
Hendricks	NULL
Taylor	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
.	NULL

1996	NULL
.	NULL

Implication	NULL
of	NULL
the	NULL
GRB2-associated	NULL
phosphoprotein	NULL
SLP-76	NULL
in	NULL
TCR-me-diated	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:1937	NULL
.	NULL

Hentsch	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Mouzaki	NULL
,	NULL
I.	NULL
Pfeuffer	NULL
,	NULL
D.	NULL
Rungger	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
weak	NULL
,	NULL
fine-tuned	NULL
binding	NULL
of	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
contributes	NULL
to	NULL
its	NULL
T	NULL
cell-restricted	NULL
activity	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2657	NULL
.	NULL

Tsuruta	NULL
,	NULL
L.	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
N.	NULL
Koyano	NULL
Nakagawa	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1995	NULL
.	NULL

Cyclic	NULL
AMP	NULL
inhibits	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
through	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
site	NULL
,	NULL
and	NULL
transfection	NULL
of	NULL
NF-AT	NULL
cDNAs	NULL
abrogates	NULL
the	NULL
sensitivity	NULL
of	NULL
EL-4	NULL
cells	NULL
to	NULL
cyclic	NULL
AMP	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
5255	NULL
.	NULL

Jonat	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
K.	NULL
K.	NULL
Park	NULL
,	NULL
A.	NULL
C.	NULL
Cato	NULL
,	NULL
S.	NULL
Gebel	NULL
,	NULL
H.	NULL
Ponta	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1990	NULL
.	NULL

Antitumor	NULL
promotion	NULL
and	NULL
antiinflammation	NULL
:	NULL
down-modulation	NULL
of	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
)	NULL
activity	NULL
by	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Cell	NULL
62:1189	NULL
.	NULL

Pifisterer	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Annweiler	NULL
,	NULL
C.	NULL
Ullmer	NULL
,	NULL
L.	NULL
M.	NULL
Corcoran	NULL
,	NULL
and	NULL
T.	NULL
Wirth	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
transactivation	NULL
potential	NULL
of	NULL
Oct1	NULL
and	NULL
Oct2	NULL
is	NULL
determined	NULL
by	NULL
additional	NULL
B	NULL
cell-specific	NULL
activities	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1655	NULL
.	NULL

Meuer	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
R.	NULL
E.	NULL
Hussey	NULL
,	NULL
M.	NULL
Fabbi	NULL
,	NULL
D.	NULL
Fox	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
K.	NULL
A.	NULL
Fitzgerald	NULL
,	NULL
J.	NULL
C.	NULL
Hodgdon	NULL
,	NULL
J.	NULL
P.	NULL
Protentis	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Reinherz	NULL
.	NULL

1984	NULL
.	NULL

Alternative	NULL
pathway	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
:	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
50	NULL
kDa	NULL
T1	NULL
sheep	NULL
erythrocyte	NULL
receptor	NULL
protein	NULL
.	NULL

Cell	NULL
36:897	NULL
.	NULL

Verhagen	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
B.	NULL
Schraven	NULL
,	NULL
M.	NULL
Wild	NULL
,	NULL
R.	NULL
Wallich	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
interaction	NULL
of	NULL
the	NULL
CD2	NULL
extracellular	NULL
and	NULL
intracellular	NULL
domains	NULL
with	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
CD45	NULL
and	NULL
the	NULL
£	NULL
chain	NULL
of	NULL
the	NULL
TCR/CD3/	NULL
{	NULL
complex	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:2841	NULL
.	NULL

Ponte	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Y.	NULL
Ng	NULL
,	NULL
J.	NULL
Engel	NULL
,	NULL
P.	NULL
Gunning	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1984	NULL
.	NULL

Evolutionary	NULL
conservation	NULL
in	NULL
the	NULL
untranslated	NULL
regions	NULL
of	NULL
actin	NULL
mRNAs	NULL
:	NULL
DNA	NULL
sequence	NULL
of	NULL
a	NULL
human	NULL
B-actin	NULL
cDNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:1687	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
C.	NULL
Takaoka	NULL
,	NULL
N.	NULL
Kashima	NULL
,	NULL
R.	NULL
Yoshimoto	NULL
,	NULL
and	NULL
J.	NULL
Hamuro	NULL
.	NULL

1983	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
cDNA	NULL
for	NULL
human	NULL
inter-leukin-2	NULL
.	NULL

Nature	NULL
302:305	NULL
.	NULL

Kashima	NULL
,	NULL
N.	NULL
,	NULL
C.	NULL
Nishi	NULL
Takaoka	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
S.	NULL
Taki	NULL
,	NULL
G.	NULL
Yamada	NULL
,	NULL
J.	NULL
Hamuro	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1985	NULL
.	NULL

Unique	NULL
structure	NULL
of	NULL
murine	NULL
interleukin-2	NULL
as	NULL
deduced	NULL
from	NULL
cloned	NULL
cDNAs	NULL
.	NULL

Nature	NULL
313:402	NULL
.	NULL

Nebl	NULL
,	NULL
G.	NULL
,	NULL
N.	NULL
Mermod	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
B.	NULL
Cato	NULL
.	NULL

1994	NULL
.	NULL

Post-transcriptional	NULL
down-regulation	NULL
of	NULL
expression	NULL
of	NULL
transcription	NULL
factor	NULL
NFI	NULL
by	NULL
Ha-ras	NULL
oncogene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:7371	NULL
.	NULL

Riither	NULL
,	NULL
U.	NULL
,	NULL
E.	NULL
F.	NULL
Wagner	NULL
,	NULL
and	NULL
R.	NULL
Miiller	NULL
.	NULL

1985	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
differentiation-promoting	NULL
potential	NULL
of	NULL
inducible	NULL
c-fos	NULL
genes	NULL
introduced	NULL
into	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:1775	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
A.	NULL
Allegretto	NULL
,	NULL
S.	NULL
T.	NULL
Okino	NULL
,	NULL
K.	NULL
Hattori	NULL
,	NULL
W.	NULL
J.	NULL
Boyle	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1988	NULL
.	NULL

Oncogene	NULL
ur	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
332:166	NULL
.	NULL

Garrity	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
D.	NULL
Chen	NULL
,	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Wold	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-2	NULL
transcription	NULL
is	NULL
regulated	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
level	NULL
of	NULL
coordinated	NULL
binding	NULL
of	NULL
both	NULL
constitutive	NULL
and	NULL
regulated	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:2159	NULL
.	NULL

Konig	NULL
,	NULL
H.	NULL
1991	NULL
.	NULL

Cell-type	NULL
specific	NULL
multiprotein	NULL
complex	NULL
formation	NULL
over	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
in	NULL
vivo	NULL
:	NULL
ternary	NULL
complex	NULL
formation	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:3607	NULL
.	NULL

Hiinig	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Ticfenthaler	NULL
,	NULL
K.	NULL
H.	NULL
Meyer	NULL
zum	NULL
Biischenfelde	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1987	NULL
.	NULL

Alternative	NULL
pathway	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
binding	NULL
of	NULL
CD2	NULL
to	NULL
its	NULL
cell-surface	NULL
ligand	NULL
.	NULL

Nature	NULL
326:298	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1987	NULL
.	NULL

Cell	NULL
surface	NULL
molecules	NULL
and	NULL
carly	NULL
events	NULL
involved	NULL
in	NULL
human	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

41:1	NULL
.	NULL

Bialojan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
Takai	NULL
.	NULL

1988	NULL
.	NULL

Inhibitory	NULL
effect	NULL
of	NULL
a	NULL
marine-sponge	NULL
toxin	NULL
,	NULL
okadaic	NULL
acid	NULL
,	NULL
on	NULL
protein	NULL
phosphatases	NULL
:	NULL
specificity	NULL
and	NULL
kinetics	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

256	NULL
:	NULL
283	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1810	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
F.	NULL
Holmes	NULL
,	NULL
and	NULL
Y.	NULL
Tsukitani	NULL
.	NULL

1990	NULL
.	NULL

Okadaic	NULL
acid	NULL
:	NULL
a	NULL
new	NULL
probe	NULL
for	NULL
the	NULL
study	NULL
of	NULL
cellular	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

15:98	NULL
.	NULL

Falk	NULL
,	NULL
W.	NULL
,	NULL
K.	NULL
Stricker	NULL
,	NULL
G.	NULL
Praast	NULL
,	NULL
Y.	NULL
Tsukitani	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
and	NULL
M.	NULL
Stoeck	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
mouse	NULL
IL-2	NULL
gene	NULL
by	NULL
okadaic	NULL
acid	NULL
:	NULL
synergy	NULL
with	NULL
inter-leukin-1	NULL
.	NULL

Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

13:67	NULL
.	NULL

Kronke	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
S.	NULL
K.	NULL
Arya	NULL
,	NULL
F.	NULL
Wong	NULL
Staal	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1984	NULL
.	NULL

Cyclosporin	NULL
A	NULL
inhibits	NULL
T-cell	NULL
growth	NULL
factor	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
mRNA	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:5214	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
M.	NULL
M.	NULL
Gillespie	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1987	NULL
.	NULL

T-cell	NULL
proliferation	NULL
involving	NULL
the	NULL
CD28	NULL
pathway	NULL
is	NULL
associated	NULL
with	NULL
cyclos-porine-resistant	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:4472	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Jun	NULL
family	NULL
members	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
calcium-regulated	NULL
,	NULL
cyclosporin	NULL
A-sensitive	NULL
signaling	NULL
pathway	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:188	NULL
.	NULL

47	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

OKADAIC	NULL
ACID-SENSITIVE	NULL
PHOSPHATASES	NULL
REGULATE	NULL
IL-2	NULL
EXPRESSION	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780	NULL
.	NULL

Lindsten	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
Stella	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
messenger	NULL
RNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
244:339	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
J.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Kehrl	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
phosphatases	NULL
by	NULL
okadaic	NULL
acid	NULL
induces	NULL
AP1	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9363	NULL
.	NULL

Komberg	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Y.	NULL
Lorch	NULL
.	NULL

1995	NULL
.	NULL

Interplay	NULL
between	NULL
chromatin	NULL
structure	NULL
and	NULL
transcription	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

7:371	NULL
.	NULL

Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
C.	NULL
A.	NULL
Bunker	NULL
,	NULL
and	NULL
A.	NULL
N.	NULL
Imbalzano	NULL
.	NULL

1996	NULL
.	NULL

Repression	NULL
and	NULL
activation	NULL
by	NULL
multiprotein	NULL
complexes	NULL
that	NULL
alter	NULL
chromatin	NULL
structure	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:905	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617	NULL
.	NULL

Mumby	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
G.	NULL
Walter	NULL
.	NULL

1993	NULL
.	NULL

Protein	NULL
serine/threonine	NULL
phosphatases	NULL
:	NULL
structure	NULL
,	NULL
regulation	NULL
,	NULL
and	NULL
functions	NULL
in	NULL
cell	NULL
growth	NULL
.	NULL

Physiol	NULL
.	NULL

Rev	NULL
.	NULL

73:673	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

